S 3014
Ensuring Timely Access to Generics Act of 2025
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 7:39 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Ensuring Timely Access to Generics Act of 2025 modifies the Federal Food, Drug, and Cosmetic Act to address concerns about citizen petitions being used to delay the approval of generic drugs. Specifically, it aims to prevent petitioners from submitting petitions primarily to delay applications for generic versions of medications. The bill updates the process for evaluating petitions, requiring the FDA to consider factors related to the timing and purpose of the petition, and establishes a process for dismissing lawsuits seeking to delay generic drug approvals if the petitioner fails to submit a timely petition.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.